Koneksa Launches Academic Collaboration Program for Parkinson’s Disease

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Part...

August 15, 2023 | Tuesday | News
Zetagen Raises $9.79M Series B for ZetaMet™ and ZetaMAST™ in Metastatic Lesion Treatment

ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently i...

August 14, 2023 | Monday | News
Novartis Completes Acquisition of Chinook Therapeutics

Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for USD 3.2bn upfront Deal brings two phase 3 assets in d...

August 14, 2023 | Monday | News
Genprex's REQORSA® Granted FDA Orphan Drug Designation for Small Cell Lung Cancer

ODD is in addition to Three FDA Fast Track Designations Genprex expects to dose the first patient in the­­­­ Acclaim-3...

August 11, 2023 | Friday | News
Thermo Fisher to Coordinate Transplant Stats for US NIH

T-SCCC will support initiatives seeking to ensure success of organ transplants for patients The PPD clinical research business of Thermo Fisher Scientific...

August 11, 2023 | Friday | News
PAN-TB Begins Phase 2 Trial for New TB Treatments

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the start of a phase 2b/c clinical trial, sponsored by the...

August 10, 2023 | Thursday | News
FDA Approves First Oral Treatment for Postpartum Depression

"Postpartum depression is a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness—even, in sever...

August 07, 2023 | Monday | News
Bavarian Nordic's Chikungunya Vaccine Shows Positive Phase 3 Results in Adults and Adolescents

Chikungunya vaccine candidate met all the co-primary endpoints of the Phase 3 study and was shown to be highly immunogenic in the majority of subjects 22...

August 07, 2023 | Monday | News
LianBio Begins Phase 1 Trial for SHP2 Inhibitor BBP-398 Combo with Osimertinib in EGFR-Mutated Lung Cancer

SHP2 is a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signaling with the downstream RAS/MAPK pathway to regulate cellular ...

August 04, 2023 | Friday | News
Etiometry's AI Algorithm FDA Cleared to Alert Neonatal Hypercapnia Risk

Etiometry, the leader in clinical decision-support software, announced today its IVCO2 Index™was cleared by the Food and Drug Administration for use ...

August 03, 2023 | Thursday | News
Clover Assistant Significantly Improves Early Chronic Kidney Disease Identification & Management

Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis and Progression of Chronic K...

August 02, 2023 | Wednesday | News
IDTechEx Examines the Role of Antimicrobial Technology in Combating Healthcare Infections.

Each year, millions of patients contract infectious diseases while in hospital. These HAIs not only lengthen hospital stays and utilize resources, such as ...

July 31, 2023 | Monday | News
Promising At-Home Testing for Sexually Transmitted Infections Revealed in New Research

Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research pre...

July 31, 2023 | Monday | News
Singapore's National Dental Research Institute Launches Global Oral Diseases Consortium

National Dental Centre Singapore’s research arm, the National Dental Research Institute Singapore (NDRIS) has established an international collaborat...

July 26, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close